A FACTORY worker’s family has agreed a five-figure out-of-court settlement over his death from asbestos-related disease. Michael Puddicombe died in March last year, aged 65, after a two-year battle with mesothelioma, a cancer caused by exposure to asbestos decades ago when he was working in a brake pad factory.
Thoracic surgeon and renowned mesothelioma specialist Dr. Robert Cameron will be hosting the 6th International Symposium on Malignant Pleural Mesothelioma on Saturday, Sept. 24, at the UCLA School of Medicine. Cameron, director of the UCLA Comprehensive Mesothelioma Program, is a global leader in the development of the lung-sparing pleurectomy/decortication surgery and a vocal advocate for…
The post International Mesothelioma Conference Will Kick Off at UCLA appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
Lung cancer is the leading cause of cancer-related mortality worldwide. Pain is a common problem in these patients, yet inadequate or dissatisfactory management is prevalent.
A Pakenham man made a statement before his death in which he spoke about exposure to asbestos which went on to cause his fatal condition, an inquest has heard. Brian Buckle, 75, died at his home in Fen Road, on May 16, the inquest at Bury St Edmunds wa…
The Australian Asbestos Safety and Eradication Agency is warning of another wave of mesothelioma cases amongst home renovators who are failing to recognise asbestos products. The Agency’s CEO, Peter Tighe says their latest research indicates that Do it Yourself home renovators are more ignorant about asbestos dangers than they were two years ago.
National data experts have – for the first time – predicted how many people with cancer can expect to survive a decade. The new figures, from the Office for National Statistics , show what proportion of people newly-diagnosed in 2015 can expect to surv…
National data experts have – for the first time – predicted how many people with cancer can expect to survive a decade. The new figures, from the Office for National Statistics , show what proportion of people newly-diagnosed in 2015 can expect to surv…
Medical oncologist Dr. Rama Balaraman isn’t expecting any miracles from the pleural mesothelioma clinical trial involving nintedanib, the small-molecule enzyme inhibitor. She is expecting progress. Balaraman, at Florida Cancer Affiliates in Ocala, is participating in an international, multicenter trial that will expand the use of nintedanib within the U.S., giving patients another weapon in this…
The post Researchers Test Nintedanib in Mesothelioma Clinical Trial appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
The local authority said it could not comment on Mr Nicol’s case, adding that any claims would be handled by solicitors. He believes that he came into contact with asbestos while refurbishing council properties in Inverness.
The Baylor College of Medicine Mesothelioma Treatment Center at Baylor St. Luke’s Medical Center has begun enrolling patients in a clinical research study looking at an investigational drug in patients with malignant pleural mesothelioma who have started on chemotherapy or whose cancer has progressed after initial chemotherapy. Pleural mesothelioma is a rare and aggressive cancer that develops in the pleura, a thin layer of tissue that surrounds the lungs.
The Baylor College of Medicine Mesothelioma Treatment Center at Baylor St. Luke’s Medical Center has begun enrolling patients in a clinical research study looking at an investigational drug in patients with malignant pleural mesothelioma who have started on chemotherapy or whose cancer has progressed after initial chemotherapy. Pleural mesothelioma is a rare and aggressive cancer that develops in the pleura, a thin layer of tissue that surrounds the lungs.
DOCTORS are to be given further guidance on how to diagnose asbestos-related disease in the hope of improving care for sufferers. Clydeside Action on Asbestos , which helps people with mesothelioma, has developed a new initiative designed to help GPs s…
DOCTORS are to be given further guidance on how to diagnose asbestos-related disease in the hope of improving care for sufferers. Clydeside Action on Asbestos , which helps people with mesothelioma, has developed a new initiative designed to help GPs s…
A New Haven jobsite received 17 violations for allegedly failing to protect workers from exposure to asbestos.
The research plan of the CRADA is designed to develop a novel AML MRD assay for monitoring the expression of multiple genes that can document the kinetics of minimal residual disease in acute myeloid leukemia during treatment with SELLAS’ most advanced product candidate, galinpepimut-S, the Company’s WT1 cancer vaccine. Galinpepimut-S is a late clinical-stage cancer immunotherapy being developed to target hematologic cancers and solid tumors, including AML, malignant pleural mesothelioma , multiple myeloma, ovarian cancer, and multiple other cancers.